These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 8513840)
21. Effects of D-002, a product isolated from beeswax, on gastric symptoms of patients with osteoarthritis treated with piroxicam: a pilot study. Illnait J; Terry H; Más R; Fernández L; Carbajal D J Med Food; 2005; 8(1):63-8. PubMed ID: 15857212 [TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of piroxicam revisited. A global meta-analysis of randomised clinical trials. Richy F; Scarpignato C; Lanas A; Reginster JY Pharmacol Res; 2009 Oct; 60(4):254-63. PubMed ID: 19467328 [TBL] [Abstract][Full Text] [Related]
23. Peptic ulcer and gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drug use in patients younger than 65 years. A large health maintenance organization cohort study. Lanza LL; Walker AM; Bortnichak EA; Dreyer NA Arch Intern Med; 1995 Jul; 155(13):1371-7. PubMed ID: 7794085 [TBL] [Abstract][Full Text] [Related]
24. Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding. Massó González EL; Patrignani P; Tacconelli S; García Rodríguez LA Arthritis Rheum; 2010 Jun; 62(6):1592-601. PubMed ID: 20178131 [TBL] [Abstract][Full Text] [Related]
25. Relative bioavailability of two oral formulations of piroxicam 20 mg: a single-dose, randomized-sequence, open-label, two-period crossover comparison in healthy Mexican adult volunteers. Palma-Aguirre JA; Lopez-Gamboa M; Cariño L; Burke-Fraga V; González-de la Parra M Clin Ther; 2010 Feb; 32(2):357-64. PubMed ID: 20206793 [TBL] [Abstract][Full Text] [Related]
26. Channelling bias and the incidence of gastrointestinal haemorrhage in users of meloxicam, coxibs, and older, non-specific non-steroidal anti-inflammatory drugs. MacDonald TM; Morant SV; Goldstein JL; Burke TA; Pettitt D Gut; 2003 Sep; 52(9):1265-70. PubMed ID: 12912856 [TBL] [Abstract][Full Text] [Related]
27. Enhanced gastric mucosal haemostasis after upper gastrointestinal haemorrhage. Allison MC; Fullarton GM; Brown IL; Crean GP; McColl KE Gut; 1991 Jul; 32(7):735-9. PubMed ID: 1855678 [TBL] [Abstract][Full Text] [Related]
28. Comparative study of the multiple dose pharmacokinetics and the tolerance of a new NSAID (droxicam) versus piroxicam in healthy volunteers. Martínez L; Sánchez J; Roser R; García-Barbal J; Bartlett A; Estruch J; Sagarra R; Puig S; Costa A Methods Find Exp Clin Pharmacol; 1988 Nov; 10(11):729-37. PubMed ID: 3221746 [TBL] [Abstract][Full Text] [Related]
30. Mucosal damage induced by preferential COX-1 and COX-2 inhibitors: role of prostaglandins and inflammatory response. Villegas I; La Casa C; de la Lastra CA; Motilva V; Herrerías JM; Martín MJ Life Sci; 2004 Jan; 74(7):873-84. PubMed ID: 14659976 [TBL] [Abstract][Full Text] [Related]
31. Piroxicam and upper gastrointestinal haemorrhage. Ward K; Weir DG Ir Med J; 1982 Jan; 75(1):10-1. PubMed ID: 6979527 [No Abstract] [Full Text] [Related]
32. Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs. García Rodríguez LA; Cattaruzzi C; Troncon MG; Agostinis L Arch Intern Med; 1998 Jan; 158(1):33-9. PubMed ID: 9437376 [TBL] [Abstract][Full Text] [Related]
33. The acute action of fenbufen and piroxicam on the gastric mucosa as measured by gastric microbleeding. Collins AJ; Notarianni LJ J Int Med Res; 1984; 12(3):179-83. PubMed ID: 6610580 [TBL] [Abstract][Full Text] [Related]
34. Plasma and synovial fluid concentrations of piroxicam during prolonged treatment with piroxicam pivalic ester. Chérié Lignière G; Montagnani G; Alberici M; Acerbi D Arzneimittelforschung; 1987 May; 37(5):560-3. PubMed ID: 3619977 [TBL] [Abstract][Full Text] [Related]
35. Hospitalization for gastrointestinal bleeding associated with non-steroidal anti-inflammatory drugs among elderly patients using low-dose aspirin: a retrospective cohort study. Rahme E; Bardou M; Dasgupta K; Toubouti Y; Ghosn J; Barkun AN Rheumatology (Oxford); 2007 Feb; 46(2):265-72. PubMed ID: 16844699 [TBL] [Abstract][Full Text] [Related]
37. [Upper digestive hemorrhage caused by tenoxicam. A pediatric case]. Lorenzo Riera A; Ramos Varela JC; Peña Quintana L; Ramos Santos S Aten Primaria; 1992 Oct; 10(5):800-1. PubMed ID: 1472609 [No Abstract] [Full Text] [Related]
38. Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors. Battistella M; Mamdami MM; Juurlink DN; Rabeneck L; Laupacis A Arch Intern Med; 2005 Jan; 165(2):189-92. PubMed ID: 15668365 [TBL] [Abstract][Full Text] [Related]
39. Upper gastrointestinal haemorrhage associated with low-dose aspirin and anti-thrombotic drugs - a 6-year analysis and comparison with non-steroidal anti-inflammatory drugs. Taha AS; Angerson WJ; Knill-Jones RP; Blatchford O Aliment Pharmacol Ther; 2005 Aug; 22(4):285-9. PubMed ID: 16097994 [TBL] [Abstract][Full Text] [Related]
40. A pharmacokinetic and endoscopic comparison of an oral and an experimental buccal piroxicam formulation. Mueller BA; Rex DK; Figueroa N; Greene P; Brater DC Pharmacotherapy; 1992; 12(2):93-7. PubMed ID: 1570233 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]